相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteomic Characterization of a Mouse Model of Familial Danish Dementia
Monica Vitale et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Identification of Isocitrate Dehydrogenase 1 as a Potential Diagnostic and Prognostic Biomarker for Non-small Cell Lung Cancer by Proteomic Analysis
Fengwei Tan et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Passenger deletions generate therapeutic vulnerabilities in cancer
Florian L. Muller et al.
NATURE (2012)
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Sang-Min Jeon et al.
NATURE (2012)
LKB1/AMPK/mTOR signaling pathway in hematological malignancies From metabolism to cancer cell biology
Alexa S. Green et al.
CELL CYCLE (2011)
Proteomic Signatures in Thapsigargin-Treated Hepatoma Cells
Giuseppina Amodio et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation
David Liska et al.
CLINICAL CANCER RESEARCH (2011)
Hypoxia and energetic tumour metabolism
M. Christiane Brahimi-Horn et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Decreased lactate dehydrogenase B expression enhances claudin 1-mediated hepatoma cell invasiveness via mitochondrial defects
June-Hyung Kim et al.
EXPERIMENTAL CELL RESEARCH (2011)
Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy
Giuseppe Spadaro et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
Proteomics characterization of gastrokine 1-induced growth inhibition of gastric cancer cells
Guang-Rong Yan et al.
PROTEOMICS (2011)
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
Kimio Yonesaka et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
Xin Lu et al.
CLINICAL CANCER RESEARCH (2010)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction
Sen-Tien Tsai et al.
EUROPEAN JOURNAL OF CANCER (2010)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Abnormalities in Glucose Uptake and Metabolism in Imatinib-Resistant Human BCR-ABL-Positive Cells
Douglas J. Kominsky et al.
CLINICAL CANCER RESEARCH (2009)
Biomarkers Predicting Clinical Outcome of Epidermal Growth Factor Receptor-Targeted Therapy in Metastatic Colorectal Cancer
Salvatore Siena et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome
David B. Shackelford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs
R. Bianco et al.
BRITISH JOURNAL OF CANCER (2008)
Kidney Cancer: Now Available in a New Flavor
William G. Kaelin
CANCER CELL (2008)
Vascular endothelial growth factor receptor-1 contributes to resistance to anti-epidermal growth factor receptor drugs in human cancer cells
Roberto Bianco et al.
CLINICAL CANCER RESEARCH (2008)
Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741
Hanna K. Sanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas
Quynh-Thu Le et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Hypoxia signalling controls metabolic demand
M. Christiane Brahimi-Horn et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Glucose metabolism and cancer
Reuben J. Shaw
CURRENT OPINION IN CELL BIOLOGY (2006)
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia
D. Perrotti et al.
BRITISH JOURNAL OF CANCER (2006)
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
James L. Tatum et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Rosa Bernardi et al.
NATURE (2006)
Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
R Bianco et al.
ENDOCRINE-RELATED CANCER (2005)
Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma
AP Venook
CANCER (2005)
PP2A: the expected tumor suppressor
V Janssens et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy
F Ciardiello et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic impact of hypoxia-inducible factors 1α and 2α in colorectal cancer patients:: Correlation with tumor angiogenesis and cyclooxygenase-2 expression
H Yoshimura et al.
CLINICAL CANCER RESEARCH (2004)
Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes
J Brugarolas et al.
CANCER CELL (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Proteins from bovine tissues and biological fluids: Defining a reference electrophoresis map for liver, kidney, muscle, plasma and red blood cells
F Talamo et al.
PROTEOMICS (2003)
Hypoxic prostate/muscle Po2 ratio predicts for biochemical failure in patients with prostate cancer:: Preliminary findings
B Movsas et al.
UROLOGY (2002)
HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis:: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression
E Laughner et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
